Hep C Calculator
The Hep C Calculator was developed by Massachusetts General Hospital and Harvard Medical School, with the support of WHO and UNITAID. It is an interactive tool which evaluates the cost-effectiveness of DAAs for the treatment of hepatitis C and enables you to assess different scenarios for 28 countries. Click here to use the calculator.
Video: Different financing mechanisms for viral hepatitis programmes
The video of this session from the World Hepatitis Summit 2017, includes presentations which explore potential hepatitis financing mechanisms that will be required for countries to launch, accelerate and sustain public health responses to viral hepatitis. Many of the mechanisms discussed are also featured throughout the website.
Video: Financing for sustainability
This video features a series of presentations given at the World Hepatitis Summit in 2017 which address the sustainable financing of a hepatitis programme within a whole health systems approach.
WHS: SD4 financing presentation
This presentation was given by Charles Gore, President of the World Hepatitis Alliance, 2007-2017, at the World Hepatitis Summit 2017 when he launched the website. It sets out a strategic approach to financing hepatitis and is a useful summary of the website. Click here to view the presentation.
Published 2017
Report of the WISH Viral Hepatitis Forum 2018
Eliminating Viral Hepatitis: The Investment Case
This report provides the business case for investing in viral hepatitis elimination programmes and sets out recommendations on how country governments and global donors can maximise their investments to achieve viral hepatitis elimination. Click here to view the report.
Burnet-Optima Hepatitis C (HCV) model
This model can be used to help inform target setting, prioritisation strategies, resource allocations and to develop investment cases for evidence-based strategies to eliminate hepatitis C. Click here to view the model.
The HepB Calculator
The HepB Calculator was developed by the Asian Liver Center at Stanford University, the School of Public Health University of Michigan and the World Health Organization. Users are able to enter specific costs relating to hepatitis B disease management and treatment for 28 countries. The calculator then models health and cost outcomes over a set time period, showing scenarios with and without hepatitis B treatment included. This enables users to see how much treatment can increase health for someone living with hepatitis B and if it is cost saving in the long term. Click here to view the calculator.